- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2008
- Public Summary Document (PSD) March 2008 PBAC Meeting - PDF
Posaconazole – March 2008
Posaconazole, oral suspension, 40 mg per mL, 105 mL, Noxafil, March 2008
Last updated
4 July 2008